Idealex

Home

        Welcome to Beesawa Biotech Limited Investor Relations. Here, we feature comprehensive information on all aspects of the Company that concern and interest the investor. From access to financial data, stock value, FAQs and more, we give our existing and potential investors all relevant data and the overall progress of the company.

        Beesawa Biotech Limited is a specialty pharmaceutical and agropharma Company engaged in the development, manufacture and commercialization of pharmaceutical and agro products. We employ 25 people and selling our products in whole country. Beesawa operates state-of-the art manufacturing facilities that produce high quality pharma and agro products. We focus on commercializing unique generic products.

Vision 2015

        1. To be among the top most biotech Company in India.

        2. To create wealth for our investors above industry standard.

        3. Company land holding approx 5000 acres (value in Rs.10000.00 Lac approx)

        4. To establish 10 formulation units in all parts of India.

Valuation of Company’s Assets

In the current financial year company’s land bank will be approximately 600 acre after present land acquisition and merger of other companies. The Company is expecting 1000 acre land bank in the financial year 2011-12 and The valuation will be Rs. 5000.00 Lac. With other assets, Plants and Machinery, and Buildings. The Company is projecting Valuation Rs. 10000.00 Lac with book value of Rs. 100/- per share and EPS 25 per share within three years span.

Processing and Manufacture

The Company believes in steady growth, horizontal and vertical. As a forward integration, the Company plans to install processing units for agriculture, herbal products like spices, green peas, stevia, tulsi, papain etc. Company’s R & D Centre, an innovative Centre for Excellent Products, Beesawa is going to set-up 4000-5000 sq.ft. area. Competent scientists, chemists and pharmacists are working for the centre and they are all having expertise in their field of specialization. The state of the art facilities consists R & D Centre, Formulation units and Extraction Units. The future association is expected to Biocon, Hindustan Lever, ITC, Dabur and other companies which are engaged ot process and manufacture of agro, herbal and pharma products.

Other News

Expansion of “Vegetable Park” and Stevia Cultivation
The Company proposes to increase its area of cultivation to around 400 acres in the financial year 2011-12 with the expected turnover of Rs.1000-1200 Lac. This will contribute revenue of Rs.550-600 Lac. The Company will not only increase its area of cultivation but will also take steps for increasing the per acre production.